This week's Fierce Drug Delivery is brought to you by Path AI.

Webinar: Unlocking the Tumor Microenvironment with PathAI

Wednesday, October 26, 2022 | 2pm ET / 11am PT

Targeting of the tumor microenvironment (TME) is recognized as a promising area in oncology drug development due to the critical role of the TME, including tumor cells, stromal features, nuclear features, immune cells, tertiary lymphoid structures, and other important features, in regulating disease progression and therapeutic response. 

You’ll discover:

• How AI is key to analyzing and unlocking the secrets of disease biology within the TME from H&E whole-slide images
• The latest TME data revealing novel biomarkers and treatment targets across different oncology indications
• How biopharma companies are leveraging and incorporating AI technology across the drug discovery and development lifecycle